Lilly eyes more cancer deals, but wary of CAR-T, gene therapy

Print pagePDF pageEmail page

Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $ 8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development.


Reuters: Health News … More ادامه مطلب

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.